Trading Statement

Trading Statement

Incorporated in the Republic of South Africa
(Registration number 1987/004821/06)
Share code: MRI    ISIN: ZAE000164562
("MRI" or "the Company")


In terms of the Listings Requirements of JSE Limited, companies are required to publish a trading
statement as soon as they become reasonably certain that the financial results for the period to
be reported on will differ by more than 20% from that of the previous corresponding period.

Accordingly, a review by management of the financial results for the year ended 28 February
2020 has indicated that both the loss per share and the headline loss per share are expected to
be between 51 cents and 70 cents, reflecting an improvement of between 26.3% and 46.3%
compared to the loss per share and headline loss per share of 95 cents for the year ended
28 February 2019.

The financial information on which this trading statement is based has not been reviewed or
reported on by the Company's auditors. MRI's financial results are expected to be released on
SENS on or about 11 May 2021.

7 May 2021

Designated Adviser
Merchantec Capital

Date: 07-05-2021 04:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.